Innovative OTC Stock Financials

IMTH -  USA Stock  

USD 0.28  0.00  0.00%

Understanding current and past Innovative Medtech Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Innovative Medtech's financial statements are interrelated, with each one affecting the others. For example, an increase in Innovative Medtech's assets may result in an increase in income on the income statement. Because of this, it is necessary to analyze all of Innovative Medtech's financials over time to get the whole picture.
.
We strongly advise to harness Innovative Medtech fundamental analysis to find out if markets are presently mispricing the company. Simply put you can make use of it to find out if Innovative Medtech is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We were able to interpolate and analyze data for twenty available reported financial drivers for Innovative Medtech, which can be compared to its competitors. To make sure the equity is not overpriced, please check out all Innovative Medtech financials, including its price to sales, cash and equivalents, as well as the relationship between the Cash and Equivalents and earnings per share . As Innovative Medtech appears to be a penny stock we also urge to confirm its net income numbers. Use Innovative Medtech to protect your portfolios against small market fluctuations. The stock experiences a normal downward fluctuation but is a risky buy. Check odds of Innovative Medtech to be traded at $0.2772 in 90 days.

Innovative Fundamentals 

 
Refresh
With this module, you can analyze Innovative financials for your investing period. You should be able to track the changes in Innovative Medtech individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Chance Of Financial Distress
Over 75
Innovative Medtech has more than 75 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Innovative Medtech otc stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Innovative Medtech's official financial statements usually reflect Innovative Medtech's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Innovative Medtech. For example, before you start analyzing numbers published by Innovative accountants, it's critical to develop an understanding of what Innovative Medtech's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Innovative Medtech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Innovative Medtech's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Innovative Medtech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Innovative Medtech. Please utilize our Beneish M Score to check the likelihood of Innovative Medtech's management to manipulate its earnings.

Innovative Medtech Company Summary

Innovative Medtech competes with Becton Dickinson, Intuitive Surg, Alcon, and Baxter International. Innovative MedTech Inc., through its subsidiaries, provides health and wellness services in the United States. Innovative MedTech Inc. was incorporated in 2005 and is based in Blue Island, Illinois. Innovative Medtech operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 37 people.
InstrumentUSA OTC Stock View All
ExchangeOTC Exchange
Business Address2310 York Street
SectorHealthcare
IndustryMedical Instruments & Supplies
BenchmarkDOW
Websiteinnovativemedtechinc.com
Phone708 925 9424
CurrencyUSD - US Dollar
You should never invest in Innovative Medtech without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Innovative OTC Stock, because this is throwing your money away. Analyzing the key information contained in Innovative Medtech's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Innovative Medtech Key Financial Ratios

Generally speaking, Innovative Medtech's financial ratios allow both analysts and investors to convert raw data from Innovative Medtech's financial statements into concise, actionable information that can be used to evaluate the performance of Innovative Medtech over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Innovative Medtech reports annually and quarterly.

Innovative Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Innovative Medtech's current stock value. Our valuation model uses many indicators to compare Innovative Medtech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innovative Medtech competition to find correlations between indicators driving Innovative Medtech's intrinsic value. More Info.
Innovative Medtech is rated fifth overall in cash and equivalents category among related companies. It is rated fifth overall in current ratio category among related companies . The ratio of Cash and Equivalents to Current Ratio for Innovative Medtech is about  1,806,000 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Innovative Medtech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Innovative Medtech's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innovative Medtech's earnings, one of the primary drivers of an investment's value.

Innovative Medtech Systematic Risk

Innovative Medtech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Innovative Medtech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of one hundred nineteen. The Beta measures systematic risk based on how returns on Innovative Medtech correlated with the market. If Beta is less than 0 Innovative Medtech generally moves in the opposite direction as compared to the market. If Innovative Medtech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Innovative Medtech is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Innovative Medtech is generally in the same direction as the market. If Beta > 1 Innovative Medtech moves generally in the same direction as, but more than the movement of the benchmark. View also all equity analysis or get more info about beta statistic functions indicator.

About Innovative Medtech Financials

What exactly are Innovative Medtech Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Innovative Medtech's income statement, its balance sheet, and the statement of cash flows. Potential Innovative Medtech investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Innovative Medtech investors may use each financial statement separately, they are all related. The changes in Innovative Medtech's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Innovative Medtech's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines that you should keep in mind when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase year after year due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt to equity ratio because this number will tell you how much risk it has. If a company such as Innovative Medtech is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to try and figure out if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that net revenue of Innovative grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only grown by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Innovative Medtech December 3, 2021 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Innovative Medtech help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Innovative Medtech. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innovative Medtech based on widely used predictive technical indicators. In general, we focus on analyzing Innovative OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innovative Medtech's daily price indicators and compare them against related drivers.
Downside Deviation26.64
Information Ratio0.0833
Maximum Drawdown353.33
Value At Risk(25.00)
Potential Upside20.0
Please see Risk vs Return Analysis. Note that the Innovative Medtech information on this page should be used as a complementary analysis to other Innovative Medtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fund Screener module to find activelly-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Innovative OTC Stock analysis

When running Innovative Medtech price analysis, check to measure Innovative Medtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Medtech is operating at the current time. Most of Innovative Medtech's value examination focuses on studying past and present price action to predict the probability of Innovative Medtech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Innovative Medtech's price. Additionally, you may evaluate how the addition of Innovative Medtech to your portfolios can decrease your overall portfolio volatility.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Is Innovative Medtech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innovative Medtech. If investors know Innovative will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innovative Medtech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Innovative Medtech is measured differently than its book value, which is the value of Innovative that is recorded on the company's balance sheet. Investors also form their own opinion of Innovative Medtech's value that differs from its market value or its book value, called intrinsic value, which is Innovative Medtech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovative Medtech's market value can be influenced by many factors that don't directly affect Innovative Medtech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovative Medtech's value and its price as these two are different measures arrived at by different means. Investors typically determine Innovative Medtech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovative Medtech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.